Flow-injection chemiluminescent determination of piroxicam using tris (2,2′-bipyridyl) ruthenium(II) - Potassium permanganate system

Analytical Letters

Volumn 41, Issue 13, 2008, Pages 2412-2423

  Yu, Fengshan ^a   Chen, Fang ^a   Zheng, Shishi ^b   Chen, Lanhua ^b   Cui, Man ^c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAIBEI NORMAL UNIVERSITY   (China)

^c ANHUI UNIVERSITY   (China)

Author keywords

Chemiluminescence; Flow injection; Piroxicam; Potassium permanganate; Tris (2,2 bipyridyl) ruthenium(II)

Indexed keywords

EID: 55749095564     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710802352464     Document Type: Article

References (23)

1. Abbaspour, A. and Mirzajani, R. 2007. Electrochemical monitoring of piroxicam in different pharmaceutical forms with multi-walled carbon nanotubes paste electrode. J. Pharm. Bio. Anal., 44: 41-48.
2. Al-Kindy, S.M.Z., Suliman, F.E.O., Al-Wishahi, A.A., Al-Lawati, H.A., and Aoudia, M. 2007. Determination of piroxicam in pharmaceutical formulations and urine samples using europium-sensitized luminescence. J. Lumin., 127: 291-296.
3. Amanlou, M. and Dehpour, A.R. 1997. Rapid method for the determination of piroxicam in rat plasma using high-performance liquid chromatography. J. Chromatogr. B, 696: 317-319.
4. Amin, A.S. 2002. Spectrophotometric determination of piroxicam and tenoxicam in pharmaceutical formulations using alizarin. J. Pharm. Bio. Anal. 29: 729.
5. Arancibia, J.A. and Escandar, G.M. 2003. Two different strategies for the fluorimetric determination of piroxicam in serum. Talanta, 60: 1113-1121.
6. Barary, M.H., Hay, M.H.A., Sabry, S.M., and Belal, T.S. 2004. Spectrofluorimetric determination of 2-aminopyridine as a potential impurity in piroxicam and tenoxicam within the pharmacopoeial limit. J. Pharm. Bio. Anal., 34: 221-226.
7. Basan, H., Goger, N., Gertas, N., and Orbey, M.T. 2001. Quantitative determination of piroxicam in a new formulation (piroxicam-β-cyclodextrin) by derivative UV spectrophotometric method and HPLC. J. Pharm. Bio. Anal., 26: 171-178.
8. Crecelius, A., Clench, M.R., Richards, D.S., and Parr, V. 2004. Quantitative determination of Piroxicam by TLC-MALDI TOF MS. J. Pharm. Bio. Anal., 35: 31-39.
9. Dadashzadeh, S., Vali, A.M., and Rezagholi, N. 2002. LC determination of piroxicam in human plasma. J. Pharm. Bio. Anal., 28: 1201-1204.
10. Doliwa, A., Santoyo, S., Campanero, M.A., and Ygartua, P. 2001. Sensitive LC determination of piroxicam after in vitro transdermal permeation studies. J. Pharm. Bio. Anal., 26: 531-537.
11. Escandar, G.M., Bystol, A.J., and Campiglia, A.D. 2002. Spectrofluorimetric method for the determination of piroxicam and pyridoxine. Anal. Chim. Acta, 466: 275-283.
12. Gerardi, R.D., Barnett, N.W., and Alewis, S.W. 1999. Analytical applications of tris(2,2′-bipyridyl)ruthenium(III) as a chemiluminescent reagent. Anal. Chim. Acta, 378: 1-41.
13. Goodman, A., Goodman, L.S., Rall, T.W., and Murad, F. 1989. Las Bases Farmacologicas De La Terapeutica. 7th Ed. Panamericana: Madrid, 669.
14. 4 system. Anal. Sci., 15: 381-383.
15. Hees, T.V., Piel, G., Hassonville, Evrard, S.H., Delattre, B.L. 2002. Determination of the free/included piroxicam ratio in cyclodextrin complexes: Comparison between UV spectrophotometry and differential scanning calorimetry. Eur. J. Pharm. Sci., 15: 347-353.
16. Jager, A.D., Ellis, H., Hundt, H.K.L., Swart, K.J., and Hundt, A.F. 1999. High-performance liquid chromatographic determination with amperometric detection of piroxicam in human plasma and tissues. J. Chromatogr. B, 729: 183-189.
17. Ji, H.Y., Lee, H.W., Kim, Y.H., Jeong, D.W., and Lee, H.S. 2005. Simultaneous determination of piroxicam, meloxicam and tenoxicam in human plasma by liquid chromatography with tandem mass spectrometry. J. Chromatogr. B, 826: 214-219.
18. 4. Int. J. Environ. Anal. Chem., 75: 299-307.
19. Meng, H., Wu, F.W., He, Z.K., and Zeng, Y.E. 1999. Chemiluminescence determination of sulfite in sugar and sulfur dioxide in air using tris (2,2′-bipyridyl) ruthenium(II)-potassium system. Talanta, 48: 571-577.
20. Nagaralli, B.S., Seetharamappa, J., and Melwanki, M.B. 2002. Sensitive spectrophotometric methods for the determination of amoxycillin, ciprofloxacin and piroxicam in pure and pharmaceutical formulations. J. Pharm. Bio. Anal., 29: 859-864.
21. Pascual-Reguera, M.I., Ayora-Cañada, M.J., and Castro-Ruiz, M.S. 2002. Determination of piroxicam by solid-phase spectrophotometry in a continuous flow system. Eur. J. Pharm. Sci., 15: 179-183.
22. Robards, K. and Worsforld, P.J. 1992. Analytical applications of liquid-phase chemiluminescence. Anal. Chim. Acta, 266: 147-173.
23. Silva, M.L.S., Garcia, M.B.Q., Lima-Jose, L.F.C., and Barradob, E. 2007. Determination of Piroxicam in Pharmaceutical Formulations Combining Amperometry and Multicommutation. Electroanalysis, 19: 1362-1367.